Search

everythinglearnresearchcommunity

for

Search:↓

Multimodal recruitment effectively gathered a diverse group for an online survey on ovulation and menstruation health.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.

Women with acne have lower levels of a specific hormone marker than women without acne.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

The Chi-PCOSQ is effective for assessing health-related quality of life in Chinese women with PCOS.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.